DeepMed Research

Fibrin

Generic Name: Fibrin

Drug Type: Biotech

CAS Number: 9001-31-4

Unique Ingredient Identifier: AQ4K8I4R6F

Clinical Trials

Bioactive Glass and Platelet Rich Fibrin in Intrabony Defects

Phase 3

Completed

Conditions: Periodontal Diseases
Bone Resorption

Interventions: Drug: Bioactive Glass
Drug: Platelet rich fibrin

First Posted Date: 2016-12-05

Last Posted Date: 2016-12-05

Lead Sponsor: Dr. D. Y. Patil Dental College & Hospital

Target Recruit Count: 10

Registration Number: NCT02982681

Evaluation of Platelets Rich Fibrin and Nanohydroxyapatite in the Treatment of Intrabony Defects

Early Phase 1

Completed

Conditions: Bony Defects

Interventions: Procedure: OFD alone
Drug: Nanohydroxyapatite
Drug: Platelet rich Fibrin

First Posted Date: 2016-06-23

Last Posted Date: 2024-03-15

Lead Sponsor: King Abdulaziz University

Target Recruit Count: 60

Registration Number: NCT02810548

Locations: 🇸🇦
King Abdelaziz University. Faculty of dentistry, Jeddah, Saudi Arabia

A Study of Fibrin Sealant Plus Silver Microparticles to Prevent Incisional Hernias Following Abdominal Surgery

Phase 1

Withdrawn

Conditions: Ventral Hernia
Hernia
Abdominal Hernia

Interventions: Drug: Fibrin Sealant
Drug: Silver Microparticles

First Posted Date: 2015-10-22

Last Posted Date: 2020-02-06

Lead Sponsor: Hobart Harris

Registration Number: NCT02584153

Postoperative Bleeding Prevention in Massive Bone Tumour Resection

Phase 3

Terminated

Conditions: Blood Loss
Bone Tumour

Interventions: Drug: Tranexamic Acid
Drug: Fibrin glue
Procedure: Electrocauterization

First Posted Date: 2014-06-03

Last Posted Date: 2016-09-20

Lead Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Target Recruit Count: 56

Registration Number: NCT02153593

Locations: 🇪🇸
Hospital Universitario de San Juan de Alicante, Alicante, Spain
🇪🇸
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
🇪🇸
Hospital Universitario de Cruces, Barakaldo,, Vizcaya, Spain

Prevention of Postoperative Bleeding in Subcapital Femoral Fractures

Phase 3

Completed

Conditions: Hip Fracture
Blood Loss

Interventions: Drug: Fibrin glue
Drug: Tranexamic Acid
Procedure: Electrocauterization

First Posted Date: 2014-05-30

Last Posted Date: 2016-09-20

Lead Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Target Recruit Count: 161

Registration Number: NCT02150720

Locations: 🇪🇸
Hospital Clinic, Barcelona, Spain
🇪🇸
Parc Taulí, Sabadell, Barcelona, Spain
🇪🇸
Hospital Universitari Mútua Terrassa, Terrassa, Barcelona, Spain

and more 3 locations

PLATELET RICH FIBRIN COMBINED WITH 1.2% ATORVASTATIN FOR TREATMENT OF INTRABONY DEFECTS IN CHRONIC PERIODONTITIS

Phase 2

Completed

Conditions: Periodontitis

Interventions: Drug: Platelet rich fibrin +Atorvastatin
Drug: Platelet rich fibrin
Procedure: open flap debridement

First Posted Date: 2014-04-21

Last Posted Date: 2014-04-21

Lead Sponsor: Government Dental College and Research Institute, Bangalore

Target Recruit Count: 96

Registration Number: NCT02119520

Locations: 🇮🇳
Govt dental college and research institute, Bangalore, Karnataka, India

Topical Raplixa for Surgical Bleeding in Children

Phase 2

Terminated

Conditions: Surgical Bleeding

Interventions: Drug: Raplixa
Device: Gelfoam
Drug: Rescue treatment

First Posted Date: 2014-04-17

Last Posted Date: 2020-02-05

Lead Sponsor: Mallinckrodt

Target Recruit Count: 55

Registration Number: NCT02117349

Locations: 🇺🇸
Carilion Clinic, Roanoke, Virginia, United States
🇺🇸
SGM Physician Research Consortium, LLC, Wayne, Pennsylvania, United States
🇺🇸
Nemours Children's Specialty Care, Jacksonville, Florida, United States

and more 10 locations

Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells

Phase 3

Completed

Conditions: Anal Fistula

Interventions: Drug: fibrin glue

First Posted Date: 2013-03-04

Last Posted Date: 2018-04-19

Lead Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Target Recruit Count: 80

Registration Number: NCT01803347

Locations: 🇪🇸
Hospital Clínico Lozano Blesa, Zaragoza, Aragón, Spain
🇪🇸
Hospital Clínico Universitario, Salamanca, Castilla-Leon, Spain
🇪🇸
Hospital Universitario La Paz, Madrid, Spain

and more 2 locations

Fibrin Sealant in Preventing Fluid Build Up During Surgery in Patients Undergoing Breast Reconstruction

Not Applicable

Terminated

Conditions: Breast Cancer
Perioperative/Postoperative Complications

Interventions: Drug: fibrin sealant (Beriplast P, TISSEEL VH)
Procedure: breast reconstruction

First Posted Date: 2012-07-25

Last Posted Date: 2022-11-02

Lead Sponsor: OHSU Knight Cancer Institute

Target Recruit Count: 2

Registration Number: NCT01649505

Locations: 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States

Effect of Fibrin Sealant on Early Wound Healing

Phase 4

Completed

Conditions: Periodontitis

Interventions: Drug: Suture
Drug: Fibrin Sealant

First Posted Date: 2012-02-24

Last Posted Date: 2012-12-25

Lead Sponsor: Chhattisgarh Dental College and Research Institute

Target Recruit Count: 15

Registration Number: NCT01538927

Locations: 🇮🇳
Chhattisgarh Dental College and Research Institute, Raj Nandgaon, Chhattisgarh, India

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy